Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0000000000000091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Erlotinib in Symptomatic Brain Metastases From a Lung Adenocarcinoma With a Sensitizing EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET -Rearranged Lung Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.01-78 the Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

CyberKnife Therapy of 24 Multiple Brain Metastases From Lung Cancer: A Case Report

Oncology Letters
Cancer ResearchOncology
2013English

Case Report: Chemotherapy in Conjunction With Blood–Brain Barrier Disruption for a Patient With Germ Cell Tumor With Multiple Brain Metastases

Clinical Genitourinary Cancer
OncologyUrology
2018English

Can We Omit Radiotherapy in Case of Brain Metastases for Patients With Mutant EGFR Lung Adenocarcinoma?

Translational Lung Cancer Research
Oncology
2017English

Quick Regression of Brain Metastases From Lung Adenocarcinoma With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Case Report and Literature Review

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy